Compile Data Set for Download or QSAR
maximum 50k data
Found 70 Enz. Inhib. hit(s) with all data for entry = 7126
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176622(US9115121, 13)
Affinity DataIC50:  0.400nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176606(US9115121, 58)
Affinity DataIC50:  1nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176668(US9115121, 65)
Affinity DataIC50:  1nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176645(US9115121, 37)
Affinity DataIC50:  1nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176604(US9115121, 46)
Affinity DataIC50:  1.20nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176620(US9115121, 11)
Affinity DataIC50:  2.70nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176660(US9115121, 53)
Affinity DataIC50:  3nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176610(US9115121, 69)
Affinity DataIC50:  3.90nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176666(US9115121, 62)
Affinity DataIC50:  4nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176656(US9115121, 49)
Affinity DataIC50:  4nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176654(US9115121, 47)
Affinity DataIC50:  4nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176638(US9115121, 30)
Affinity DataIC50:  5nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176602(US9115121, 18)
Affinity DataIC50:  7nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176623(US9115121, 14)
Affinity DataIC50:  8nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176661(US9115121, 54)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176605(US9115121, 56)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176671(US9115121, 70)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176616(US9115121, 7)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176608(US9115121, 63)
Affinity DataIC50:  10nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176619(US9115121, 10)
Affinity DataIC50:  10nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176612(US9115121, 3)
Affinity DataIC50:  11nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176641(US9115121, 33)
Affinity DataIC50:  11nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176670(US9115121, 68)
Affinity DataIC50:  11nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176655(US9115121, 48)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176603(US9115121, 20)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176615(US9115121, 6)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176601(US9115121, 12)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176657(US9115121, 50)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176614(US9115121, 5)
Affinity DataIC50:  14nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176628(US9115121, 19)
Affinity DataIC50:  14nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176637(US9115121, 29)
Affinity DataIC50:  14nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176617(US9115121, 8)
Affinity DataIC50:  14nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176624(US9115121, 15)
Affinity DataIC50:  17nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176626(US9115121, 17)
Affinity DataIC50:  17nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176644(US9115121, 36)
Affinity DataIC50:  17nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176669(US9115121, 66)
Affinity DataIC50:  18nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176652(US9115121, 44)
Affinity DataIC50:  18nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176667(US9115121, 64)
Affinity DataIC50:  19nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176649(US9115121, 41)
Affinity DataIC50:  20nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176607(US9115121, 61)
Affinity DataIC50:  21nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176663(US9115121, 57)
Affinity DataIC50:  21nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176648(US9115121, 40)
Affinity DataIC50:  21nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176632(US9115121, 24)
Affinity DataIC50:  21nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176658(US9115121, 51)
Affinity DataIC50:  23nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176665(US9115121, 60)
Affinity DataIC50:  23nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176650(US9115121, 42)
Affinity DataIC50:  24nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176630(US9115121, 22)
Affinity DataIC50:  24nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176664(US9115121, 59)
Affinity DataIC50:  25nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176633(US9115121, 25)
Affinity DataIC50:  27nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176635(US9115121, 27)
Affinity DataIC50:  27nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 70 total ) | Next | Last >>
Jump to: